Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Traws Pharma (TRAW) Receivables - Net (2016 - 2025)

Traws Pharma (TRAW) has disclosed Receivables - Net for 12 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net fell 6.13% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 6.13% decrease, with the full-year FY2024 number at $1.8 million, up 9705.56% from a year prior.
  • Receivables - Net was $2.0 million for Q3 2025 at Traws Pharma, up from $1.3 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.1 million in Q3 2024 to a low of $17000.0 in Q1 2023.
  • A 5-year average of $483894.7 and a median of $28000.0 in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: crashed 39.29% in 2023, then soared 11683.33% in 2024.
  • Traws Pharma's Receivables - Net stood at $28000.0 in 2021, then grew by 3.57% to $29000.0 in 2022, then plummeted by 37.93% to $18000.0 in 2023, then soared by 9705.56% to $1.8 million in 2024, then increased by 12.8% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Receivables - Net are $2.0 million (Q3 2025), $1.3 million (Q2 2025), and $1.7 million (Q1 2025).